Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIIPL Tdap versus Boostrix in healthy adults, adolescents, and children
2019-002706-46Phase 2Completed
- Sponsor
- Vakzine Projekt Management
- Start
- Jul 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of tetanus toxoid + reduced diphtheria toxoid + acellular pertussis vaccine in diphtheria, Tetanus and pertussis (2 arms), sponsored by Vakzine Projekt Management. Started Jul 2019; status: completed.
02
Drugs
tetanus toxoid + reduced diphtheria toxoid + acellular pertussis vaccine
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on 2019-002706-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002706-46.